European Case Law Identifier: | ECLI:EP:BA:2012:T170511.20121115 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 15 November 2012 | ||||||||
Case number: | T 1705/11 | ||||||||
Application number: | 96119077.4 | ||||||||
IPC class: | C12N 9/12 C12N 9/96 C12N 15/00 C12P 19/34 C12Q 1/68 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Stable enzyme composition comprising a thermostable nucleic acid polymerase enzyme | ||||||||
Applicant name: | F. Hoffmann-La Roche AG | ||||||||
Opponent name: | NEW ENGLAND BIOLABS, INC. | ||||||||
Board: | 3.3.08 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Admissibility of new documents and evidence into the appeal (no) Claims as maintained by the first instance - novelty and inventive step (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t111705eu1.html
Date retrieved: 17 May 2021